trustme.bro/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim
The incremental cost-effectiveness ratio measures the economic value of a health intervention.
the verdict
SUPPORTED
the evidence backs this
refutedsupported
the weight of evidence
16 sources for · 0 against

The incremental cost-effectiveness ratio (ICER) is a standard statistic used in health economics to measure the economic value and cost-effectiveness of medical interventions by comparing relative costs and health outcomes.

Evidence for · 16
cited by 0
Reference article covering this claim directly
See more details
How claims like this are judged

Judged against reference works: claims of this kind are settled by reference works, not journal abstracts.

More for · 15
cited by 0
Reference article covering this claim directly
cited by 0
Reference article covering this claim directly
2012 · cited by 0
Discusses incremental cost and incremental effect as ratio measures in economic analysis.
1999 · cited by 0
Refers to the determination of cost-effectiveness ratios and marginal cost-effectiveness for medical endeavors.
2025 · cited by 0
Refers to assessing costs and cost-effectiveness of antiretroviral therapy interventions.
2022 · cited by 0
Mentions parallel economic analysis investigating clinical effectiveness and cost-effectiveness.
2020 · cited by 0
Evaluates cost-effectiveness and efficient techniques of colorectal cancer screening.
2023 · cited by 0
States the ICER is calculated to evaluate the cost-effectiveness of vaccination strategies.
2012 · cited by 0
Notes that ICER represents the additional cost per unit of outcome gained, serving as a popular methodology in health economics.
1995 · cited by 0
Exemplifies how incremental cost-effectiveness ratios estimate the economic value and trade-offs of health interventions.
2020 · cited by 0
Confirms ICER is routinely used by health technology assessment agencies to summarize economic evaluations of health interventions.
2011 · cited by 0
Examines whether preventive health interventions are cost-effective using incremental cost ratios.
2024 · cited by 0
Introduces the incremental cost-effectiveness ratio as a tool for economic evaluation and decision making in health.
Everything we examined (30)
  1. Wikipedia: Incremental cost-effectiveness ratioreferencesupports
  2. Wikipedia: Cost-effectiveness analysisreferencesupports
  3. Wikipedia: Comparative effectiveness researchreferencesupports
  4. Book: The New Public Healthreferenceno side takennot shown: read and judged not to bear on this claim
  5. Book: CPAP Adherencereferenceno side takennot shown: read and judged not to bear on this claim
  6. Book: Cardiovascular Therapeutics E-Bookreferencesupportsnot shown: a book whose author and subject did not establish authority here
  7. Book: Inflammatory Bowel Diseasereferenceno side takennot shown: read and judged not to bear on this claim
  8. Oxford University Press: Cost-effectiveness in health and medicinereferenceno side takennot shown: read and judged not to bear on this claim
  9. Oxford University Press: Cost-effectiveness in health and medicinereferenceno side takennot shown: read and judged not to bear on this claim
  10. John Wiley & Sons: Economic analysis in health carereferencesupports
  11. Aspen Publishers: Issues in cost accounting for health care organizationsreferencesupports
  12. AMA Press: Evidence-based to value-based medicinereferenceno side takennot shown: read and judged not to bear on this claim
  13. Aspen Publishers: Cost accounting for health care organizations : concepts and applicationsreferenceno side takennot shown: read and judged not to bear on this claim
  14. John Wiley & Sons: Cochrane handbook for systematic reviews of interventionsreferenceno side takennot shown: read and judged not to bear on this claim
  15. Oxford University Press: The cost-effectiveness of psychotherapy : a guide for practitioners, researchers, and policymakersreferenceno side takennot shown: read and judged not to bear on this claim
  16. Wikisource: Healthy Oregon Actreferenceno side takennot shown: read and judged not to bear on this claim
  17. Wikisource: Brundtland Report/Chapter 2. Towards Sustainable Developmentreferenceno side takennot shown: read and judged not to bear on this claim
  18. Wikisource: Public Law 116-136referenceno side takennot shown: read and judged not to bear on this claim
  19. Programme Grants for Applied Research: Supporting antiretroviral therapy uptake and adherence: the SUPA research programme and RCTpeer-reviewedsupports
  20. Health Technology Assessment: Exercise to prevent shoulder problems after breast cancer surgery: the PROSPER RCTpeer-reviewedsupports
  21. Risk Management and Healthcare Policy: Cost-Effectiveness Analysis of Colorectal Cancer Screening: A Systematic Reviewpeer-reviewedsupports
  22. Frontiers in Public Health: Cost-effectiveness analysis of vaccination against COVID-19 in Chinapeer-reviewedsupports
  23. Health Technology Assessment: Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localisedpeer-reviewedsupports
  24. Health Technology Assessment: C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCTpeer-reviewedsupports
  25. OpenAIRE: Median-Based Incremental Cost-Effectiveness Ratio (ICER)peer-reviewedsupports
  26. OpenAIRE: Economic evaluation using mathematical models: the case of misoprostol prophylaxis.peer-reviewedsupports
  27. OpenAIRE: Calculating and Interpreting ICERs and Net Benefitpeer-reviewedsupports
  28. OpenAIRE: Public health and prevention in Europe: is it cost-effective?peer-reviewedsupports
  29. OpenAIRE: BLOOD CONSERVATION IN PATIENTS UNDERGOING ELECTIVE PRIMARY TOTAL HIP JOINT ARTHROPLASTY: AN ECONOMIC EVALUATIONpeer-reviewedsupports
  30. OpenAIRE: UNA REVISIÓN DE MÉTODOS DE EVALUACIÓN ECONÓMICA EN SALUDpeer-reviewedsupports
The paper trail · every fact has a biography
first checked05 Aug 2026
judged → SUPPORTED · 7505 Aug 2026
This receipt carries no identity, shared or not. Sharing publishes your connection to it, not your data.
Check your own claim
Challenge the receipt
trust me, bro: win the argument, pass the class, survive peer review.
This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work · Dispute this receipt